PHARMACEUTICAL MYTHOLOGY: Do Not Take Aspirin as a Blood Thinner
A definitive study on the uselessness of aspirin taken for cardiovascular disease is published in no less than the Journal of the American Medical Association (JAMA). The study finds no benefit at all in giving aspirin to people at risk for heart disease. Not only does aspirin not prevent heart attacks, but patients who take daily aspirin (or, who take ibuprofen regularly) actually double their risk of a fatal heart attack.
Thousands of people each year die of side effects of aspirin, including upper GI bleeding.
Aspirin also increases the incidence of hemorrhagic strokes (which constitute about 20% of all strokes), and taking daily aspirin can actually cause the formation of a blood clot, rather than preventing it.
Another side effect of regular aspirin use is hearing loss.
Yet another alarming side effect for those who use aspirin regularly, particularly people who take aspirin daily in the mistaken notion that it reduces risk of heart attacks and strokes, is wet macular degeneration and ultimately blindness.
Fowkes, et al. Aspirin for prevention of cardiovascular events. JAMA, March 2010.
This study looks at the effectiveness of aspirin in preventing cardiovascular events in people with atherosclerosis, indicating an increased risk of cardiovascular and cerebrovascular events, but who have never experienced such an event. The results are:
Aspirin gives zero protection against initial fatal or non-fatal coronary event.
Aspirin gives zero protection against initial stroke.
Aspirin gives zero protection against the development of angina.
Aspirin gives zero protection against the development of intermittent claudication.
Aspirin gives zero protection against transient ischemic attack (mini strokes).
Aspirin gives zero protection against all-cause mortality.
However --- the aspirin group is 70% more likely to be hospitalized for an initial event of major hemorrhage.
Ogawah, et al. Low-dose aspirin for primary prevention of atherosclerotic events in patients with Type II diabetes. JAMA, November 2008.
This study looks specifically at low-dose aspirin for prevention of cardiovascular events in those with Type II diabetes, and thus at high risk for heart attack or stroke.
This study concludes that in patients with Type II diabetes, low-dose aspirin does not reduce the risk of cardiovascular events, either heart attack or stroke.
Ridkerpm, et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med. March, 2005.
This study looks specifically at the use of aspirin to prevent heart attacks and strokes in women. The study finds absolutely no benefit in preventing heart attacks. It does show a slight decrease in the incidence of ischemic stroke in women who take aspirin, but, an increase in hemorrhagic stroke.
Curhan, et al. Analgesic use and the risk of hearing loss in men. Am J Med. March, 2010.
Chronic use of painkillers such aspirin, Tylenol (acetaminophen), and ibuprofen causes hearing loss. Those who use Tylenol only twice weekly have double the risk of hearing loss; ibuprofen increases hearing loss by two-thirds, and aspirin by one-third.
Studies published in both the Journal of the American Medical Association and in the British Journal of Ophthalmology show that low-dose aspirin taken over a period of years increases the incidence of wet macular degeneration (the leading cause of blindness). The increased incidence of macular degeneration in aspirin users is only minimally significant when the study is adjusted for confounding factors such as smoking. However, the incidence of macular degeneration in aspirin users with cardiovascular disease (the very people who are snookered into taking aspirin as a blood thinner) is statistically significant to a high degree.
Research done at the University of California and reported in the British Medical Journal shows that elderly men and women who take aspirin every day almost double their chances of developing ischemic heart disease. This study also shows that there is an increased incidence of both kidney and colon cancer in those taking aspirin on a daily basis. The study also shows that there is an increased death rate in the aspirin users from hemorrhagic stroke, along with morbidity from bleeding ulcers and other intestinal bleeding.
The truth regarding aspirin's failure to prevent heart attacks and strokes has been known for over 20 years.
A study done at the University of Sidney in Australia and reported in the Medical Tribune on June 25, 1992 shows that patients with some degree of blockage of arteries to the brain are three times more likely to have a stroke if they are taking aspirin, and that increased incidence of stroke is from as little as a half tablet daily.
The original study from long ago purporting to show that aspirin decreases the risk of a second heart attack did not use pure aspirin but aspirin combined with magnesium in the form of the product Bufferin. It turns out that the slight benefit that was achieved in decreasing heart attacks was entirely due to the magnesium supplementation and had nothing whatsoever to do with the aspirin. This study was done by the AMA and was called the Physicians Health Study. What the study also showed was that even though the incidence of heart attacks was reduced in these people taking the aspirin accompanied by magnesium, the incidence of strokes increased in an amount almost exactly equal to the decrease in heart attacks. --- So, the overall mortality rate of the group taking the buffered aspirin was unchanged from the control group. --- In summary, the incidence of heart attacks was reduced slightly but was entirely due to the magnesium, and the incidence of strokes increased.
Shortly after the Physicians Health Study a British study was done to confirm it and was completely unable to do so. The British study used only aspirin (with no magnesium) and proved conclusively that aspirin had absolutely nothing to do with lowering the incidence of heart attacks. Furthermore, the people in the British study suffered so severely from stomach and intestinal bleeding that many subjects had to drop out of the study.
Final summary: Why would you take a drug that increases your chances of hemorrhagic stroke, increases your chances of forming certain types of blood clots, causes upper GI bleeding, causes hearing loss, and may increase your chance of wet macular degeneration and colon or kidney cancer, when all you get in return is blood that is a bit thinner? It is all the more absurd to consider taking a dangerous drug (--- yes --- from what you have read above, you must understand that aspirin is very definitely in the category of dangerous drug), when the blood thinning effects can be achieved quite naturally with a healthy diet of meat, fish, poultry, eggs, and cheese, plus lots of vegetables.
Furthermore, there are nutrients abundantly supplied in NUTRI-SPEC supplements that thin the blood. These supplements include:
Oxy Power (Diphasic P.M.)
Many other NUTRI-SPEC supplements are specifically protective against various forms of cardiovascular disease. These include:
Go Power (Diphasic A.M.)
Aspirin (as well as ibuprofen and naproxen, but not Tylenol/acetaminophen) is fine for occasional short-term use for relief of inflammatory pain. But to protect and strengthen your cardiovascular system, rely on NUTRI-SPEC rather than being snookered into taking drugs that are certain to hurt you.